Faces in Clouds

Humans are wired to see patterns, even when none exist. When suggestive noise is mistaken for signal, there is risk of false positives, also called Type I errors.

In genomics, that confusion becomes dangerous.

When you analyze ~60,000 genes across ~1,200 patients, naive testing at α = 0.05 produces roughly 3,000 false positives. Not because the biology is rich but because high-dimensional geometry guarantees extremity. If the number of predictors far exceeds the number of patients (p >> n), every patient has thousands of opportunities to look “special.” In that regime, everyone becomes an outlier. And outliers create mirages.

Apophenia, the tendency to connect unrelated dots, is both a cognitive bias and also the name of a statistical modeling library. In high-dimensional biomedical modeling, it becomes a structural risk. This is why reproducibility matters and partially why there is a reproducibility crisis. All too often, we are simply fooled by randomness. At Midnight Mechanism, we don’t stop at statistical significance. We apply dimensional reduction, penalized modeling, cross-validation, and stability checks to pressure-filter the noise from every signal.

If an association disappears under stochastic perturbation (insert link to next blog post), it was a cloud. If it persists, it earns attention.

In my recent work, Genes That Matter, several genes emerged as survival-associated after rigorous modeling. They are not billion-dollar oncogenic drug targets, and we do not pretend they are. Their value lies in risk stratification and treatment interaction modeling — precisely where statistical discipline matters most.

In high-dimensional medicine, reproducibility isn’t just academic hygiene. It’s ethical responsibility.